PF-06700841

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates
Name
PF-06700841
Accession Number
DB15003
Type
Small Molecule
Groups
Investigational
Description

PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers).

Structure
Thumb
Synonyms
Not Available
External IDs
PF-06700841
Categories
UNII
3X8387Q25N
CAS number
1883299-62-4
Weight
Average: 389.411
Monoisotopic: 389.17756465
Chemical Formula
C18H21F2N7O
InChI Key
BUWBRTXGQRBBHG-MJBXVCDLSA-N
InChI
InChI=1S/C18H21F2N7O/c1-25-8-11(7-22-25)23-17-21-5-4-15(24-17)26-9-12-2-3-13(10-26)27(12)16(28)14-6-18(14,19)20/h4-5,7-8,12-14H,2-3,6,9-10H2,1H3,(H,21,23,24)/t12-,13+,14-/m0/s1
IUPAC Name
4-[(1R,5S)-8-[(1S)-2,2-difluorocyclopropanecarbonyl]-3,8-diazabicyclo[3.2.1]octan-3-yl]-N-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-amine
SMILES
CN1C=C(NC2=NC=CC(=N2)N2C[C@@H]3CC[C@H](C2)N3C(=O)[C@@H]2CC2(F)F)C=N1

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
ChemSpider
71107316
HET
G4J
PDB Entries
6dbm / 6dbn

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedNot AvailablePsoriasis Vulgaris (Plaque Psoriasis)1
1CompletedBasic ScienceHealthy Male Subjects1
1CompletedBasic ScienceHealthy Volunteers2
1CompletedTreatmentHealthy Volunteers2
1RecruitingBasic ScienceHealthy Volunteers1
2CompletedTreatmentAlopecia Areata (AA)1
2CompletedTreatmentChronic Plaque Psoriasis1
2Not Yet RecruitingTreatmentAcne Inversa1
2RecruitingTreatmentActive Non-segmental Vitiligo1
2RecruitingTreatmentAtopic Dermatitis (AD)1
2RecruitingTreatmentCrohn's Disease (CD)1
2RecruitingTreatmentPsoriasis1
2RecruitingTreatmentPsoriatic Arthritis1
2RecruitingTreatmentSystemic Lupus Erythematosus (SLE)1
2RecruitingTreatmentUlcerative Colitis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility1.5 mg/mLALOGPS
logP2.21ALOGPS
logP1.55ChemAxon
logS-2.4ALOGPS
pKa (Strongest Acidic)10.91ChemAxon
pKa (Strongest Basic)4.45ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area79.18 Å2ChemAxon
Rotatable Bond Count4ChemAxon
Refractivity109.73 m3·mol-1ChemAxon
Polarizability38.26 Å3ChemAxon
Number of Rings5ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 08:41 / Updated on November 02, 2019 03:28